S&P Equity Research Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: S&P Equity Research
Rating: 2.7
Author: MarketBeat

View the latest stock recommendations issued by analysts at S&P Equity Research. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from S&P Equity Research's equity research team. MarketBeat is not affiliated with or endorsed by S&P Equity Research.

Updated 10/22/2025

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 1 Last 12 Months
Buy Ratings: 1 Last 12 Months
Sell Ratings: 0 Last 12 Months
Companies Covered: 1 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
NVDA NVIDIA	$207.41 -2.4%	10/22/2025		Reiterated Rating		Positive	View details for S&P Equity Research rating of NVIDIA (NASDAQ:NVDA) on 10/22/2025
ALLY Ally Financial	$45.70 +0.6%	11/14/2022		Set Price Target	$29.50		View details for S&P Equity Research rating of Ally Financial (NYSE:ALLY) on 11/14/2022
DOW DOW	$32.93 -0.9%	9/9/2022		Lower Price Target	$70.00 ➝ $60.00	Buy	View details for S&P Equity Research rating of DOW (NYSE:DOW) on 9/9/2022
AVY Avery Dennison	$162.00 +1.4%	1/7/2021		Upgrade	$149.00 ➝ $181.00	Neutral ➝ Buy	View details for S&P Equity Research rating of Avery Dennison (NYSE:AVY) on 1/7/2021
ESNT Essent Group	$59.55 +2.3%	6/1/2020		Lower Price Target	$56.00 ➝ $48.00	In-Line ➝ Reduce	View details for S&P Equity Research rating of Essent Group (NYSE:ESNT) on 6/1/2020
GPC Genuine Parts	$107.13 +2.4%	4/8/2020		Lower Price Target	$85.00 ➝ $78.00	Neutral ➝ Buy	View details for S&P Equity Research rating of Genuine Parts (NYSE:GPC) on 4/8/2020
SCI Service Corporation International	$74.52 +0.8%	3/31/2020		Lower Price Target	$53.00 ➝ $47.00	Outperform	View details for S&P Equity Research rating of Service Corporation International (NYSE:SCI) on 3/31/2020
NXPI NXP Semiconductors	$302.89 -4.1%	1/10/2020		Boost Price Target	$145.00 ➝ $155.00		View details for S&P Equity Research rating of NXP Semiconductors (NASDAQ:NXPI) on 1/10/2020
ARWR Arrowhead Pharmaceuticals	$76.55 -0.8%	11/26/2019		Reiterated Rating		Buy	View details for S&P Equity Research rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 11/26/2019
BX Blackstone	$127.89 +2.6%	9/24/2019		Downgrade		Outperform ➝ Market Perform	View details for S&P Equity Research rating of Blackstone (NYSE:BX) on 9/24/2019
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
GLW Corning	$177.34 -5.6%	8/1/2019		Downgrade	$40.00 ➝ $30.00	Positive ➝ Neutral	View details for S&P Equity Research rating of Corning (NYSE:GLW) on 8/1/2019
RMR The RMR Group	$20.51 +0.1%	7/1/2019		Upgrade	$54.00	Market Perform ➝ Outperform	View details for S&P Equity Research rating of The RMR Group (NASDAQ:RMR) on 7/1/2019
GERN Geron	$1.18 +2.6%	9/27/2018		Lower Price Target	$2.32 ➝ $1.80		View details for S&P Equity Research rating of Geron (NASDAQ:GERN) on 9/27/2018
AAPL Apple	$299.24 +1.0%	9/11/2018		Boost Price Target	$62.50	Underweight ➝ In-Line	View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 9/11/2018
XOMA XOMA Royalty	$41.78 -0.4%	8/14/2018		Lower Price Target	$18.74 ➝ $16.26		View details for S&P Equity Research rating of XOMA Royalty (NASDAQ:XOMA) on 8/14/2018
ARWR Arrowhead Pharmaceuticals	$76.55 -0.8%	6/18/2018		Lower Price Target	$13.76 ➝ $11.68		View details for S&P Equity Research rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/18/2018
NWBO Northwest Biotherapeutics	$0.19 -0.4%	5/29/2018		Lower Price Target	$0.28 ➝ $0.23		View details for S&P Equity Research rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 5/29/2018
MNKD MannKind	$3.87 -3.3%	1/25/2018		Lower Price Target	$3.49 ➝ $2.77		View details for S&P Equity Research rating of MannKind (NASDAQ:MNKD) on 1/25/2018
NVAX Novavax	$9.20 -0.1%	1/10/2018		Lower Price Target	$36.20 ➝ $27.00		View details for S&P Equity Research rating of Novavax (NASDAQ:NVAX) on 1/10/2018
SPY SPDR S&P 500 ETF Trust	$750.33 -0.6%	12/11/2017		Initiated Coverage	$3,000.00		View details for S&P Equity Research rating of SPDR S&P 500 ETF Trust (NYSEARCA:SPY) on 12/11/2017
MVIS Microvision	$0.38 -1.4%	11/2/2017		Boost Price Target	$1.75 ➝ $2.22		View details for S&P Equity Research rating of Microvision (NASDAQ:MVIS) on 11/2/2017
MNKD MannKind	$3.87 -3.3%	5/8/2017		Lower Price Target	$1.04 ➝ $0.83		View details for S&P Equity Research rating of MannKind (NASDAQ:MNKD) on 5/8/2017
WPRT Westport Fuel Systems	$1.86 +1.6%	3/24/2017		Lower Price Target	$10.00 ➝ $8.80		View details for S&P Equity Research rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/24/2017
BLX Banco Latinoamericano de Comercio Exterior	$59.27 +1.0%	1/20/2017		Downgrade		Buy ➝ Hold	View details for S&P Equity Research rating of Banco Latinoamericano de Comercio Exterior (NYSE:BLX) on 1/20/2017
UAL United Airlines	$118.51 -1.2%	1/19/2017		Reiterated Rating		Buy	View details for S&P Equity Research rating of United Airlines (NASDAQ:UAL) on 1/19/2017
NVDA NVIDIA	$207.41 -2.4%	12/29/2016		Lower Price Target	$2.25 ➝ $0.62		View details for S&P Equity Research rating of NVIDIA (NASDAQ:NVDA) on 12/29/2016
NWBO Northwest Biotherapeutics	$0.19 -0.4%	12/15/2016		Lower Price Target	$0.73 ➝ $0.61		View details for S&P Equity Research rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 12/15/2016
GD General Dynamics	$364.45 +1.4%	12/1/2016	Todd Rosenbluth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Buy	View details for S&P Equity Research rating of General Dynamics (NYSE:GD) on 12/1/2016
LMT Lockheed Martin	$536.16 +1.1%	12/1/2016	Todd Rosenbluth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Buy	View details for S&P Equity Research rating of Lockheed Martin (NYSE:LMT) on 12/1/2016
MBOT Microbot Medical	$1.82	11/18/2016		Lower Price Target			View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 11/18/2016
WELL Welltower	$213.82 +0.5%	11/3/2016		Reiterated Rating		Positive	View details for S&P Equity Research rating of Welltower (NYSE:WELL) on 11/3/2016
TSLA Tesla	$404.66 -1.6%	10/27/2016		Reiterated Rating		Sell	View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 10/27/2016
OMER Omeros	$9.48 +1.6%	10/17/2016		Boost Price Target	$7.65 ➝ $8.63		View details for S&P Equity Research rating of Omeros (NASDAQ:OMER) on 10/17/2016
MBOT Microbot Medical	$1.82	10/6/2016		Boost Price Target	$1.07 ➝ $1.20		View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 10/6/2016
EXEL Exelixis	$52.10 -1.7%	9/28/2016		Boost Price Target	$13.41 ➝ $15.57		View details for S&P Equity Research rating of Exelixis (NASDAQ:EXEL) on 9/28/2016
GIS General Mills	$34.41 +0.4%	9/27/2016		Reiterated Rating	$70.00	Buy	View details for S&P Equity Research rating of General Mills (NYSE:GIS) on 9/27/2016
BLRX BioLineRx	$3.05 -5.9%	9/23/2016		Lower Price Target	$49.60 ➝ $44.00		View details for S&P Equity Research rating of BioLineRx (NASDAQ:BLRX) on 9/23/2016
PTNT Palatin Technologies	$27.02 -1.2%	9/22/2016		Lower Price Target	$762.50 ➝ $687.50		View details for S&P Equity Research rating of Palatin Technologies (OTCMKTS:PTNT) on 9/22/2016
SLS SELLAS Life Sciences Group	$7.53 -2.6%	9/20/2016		Lower Price Target	$19.50 ➝ $17.00		View details for S&P Equity Research rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 9/20/2016
NVAX Novavax	$9.20 -0.1%	9/16/2016		Lower Price Target	$28.80 ➝ $23.40		View details for S&P Equity Research rating of Novavax (NASDAQ:NVAX) on 9/16/2016
Trump’s secret China deal (Ad) Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors? Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all. Watch the full documentary and see which assets are positioned to benefit
MBOT Microbot Medical	$1.82	9/14/2016		Lower Price Target	$1.57 ➝ $1.31		View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 9/14/2016
NWBO Northwest Biotherapeutics	$0.19 -0.4%	9/13/2016		Lower Price Target	$0.59 ➝ $0.43		View details for S&P Equity Research rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 9/13/2016
AAPL Apple	$299.24 +1.0%	9/8/2016	Angelo Zino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Strong-Buy	View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 9/8/2016
XLF Financial Select Sector SPDR Fund	$54.35 +1.5%	9/8/2016		Reiterated Rating		Overweight	View details for S&P Equity Research rating of Financial Select Sector SPDR Fund (NYSEARCA:XLF) on 9/8/2016
BAC Bank of America	$56.79 +1.6%	8/31/2016		Reiterated Rating	$18.00	Buy	View details for S&P Equity Research rating of Bank of America (NYSE:BAC) on 8/31/2016
MNKD MannKind	$3.87 -3.3%	8/31/2016		Lower Price Target	$0.84 ➝ $0.70		View details for S&P Equity Research rating of MannKind (NASDAQ:MNKD) on 8/31/2016
KPTI Karyopharm Therapeutics	$9.10 -5.6%	8/30/2016		Lower Price Target	$135.90 ➝ $113.25		View details for S&P Equity Research rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 8/30/2016
NFLX Netflix	$78.72 -3.6%	8/25/2016		Reiterated Rating	$12.80	Buy	View details for S&P Equity Research rating of Netflix (NASDAQ:NFLX) on 8/25/2016
TGTX TG Therapeutics	$50.54 +0.5%	8/24/2016		Lower Price Target	$7.15 ➝ $6.40		View details for S&P Equity Research rating of TG Therapeutics (NASDAQ:TGTX) on 8/24/2016
AMAT Applied Materials	$568.23 -3.0%	8/21/2016	angelo zino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$31.00	Hold	View details for S&P Equity Research rating of Applied Materials (NASDAQ:AMAT) on 8/21/2016
CHKAQ Chesapeake Energy	$3.05	8/18/2016		Reiterated Rating		Hold	View details for S&P Equity Research rating of Chesapeake Energy (OTCMKTS:CHKAQ) on 8/18/2016
MBOT Microbot Medical	$1.82	8/16/2016		Lower Price Target	$1.77 ➝ $0.45		View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 8/16/2016
TELL Tellurian	$1.00 +0.2%	8/8/2016		Lower Price Target	$4.00 ➝ $3.40		View details for S&P Equity Research rating of Tellurian (NYSEAMERICAN:TELL) on 8/8/2016
FSLR First Solar	$264.36 -3.3%	8/5/2016		Downgrade	$75.00 ➝ $55.00	Buy ➝ Hold	View details for S&P Equity Research rating of First Solar (NASDAQ:FSLR) on 8/5/2016
GILD Gilead Sciences	$127.23 +2.4%	7/27/2016		Reiterated Rating		Strong-Buy	View details for S&P Equity Research rating of Gilead Sciences (NASDAQ:GILD) on 7/27/2016
VNQ Vanguard Real Estate ETF	$98.06 +0.2%	7/25/2016		Reiterated Rating		Equal Weight	View details for S&P Equity Research rating of Vanguard Real Estate ETF (NYSEARCA:VNQ) on 7/25/2016
T AT&T	$23.16 -0.5%	7/24/2016	Angelo Zino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$46.00	Buy	View details for S&P Equity Research rating of AT&T (NYSE:T) on 7/24/2016
TSLA Tesla	$404.66 -1.6%	7/24/2016	Efraim Levy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$13.33	Sell ➝ Hold	View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 7/24/2016
HSY Hershey	$182.60 +0.8%	7/5/2016		Upgrade	$94.00 ➝ $126.00	Hold ➝ Buy	View details for S&P Equity Research rating of Hershey (NYSE:HSY) on 7/5/2016
SLS SELLAS Life Sciences Group	$7.53 -2.6%	7/1/2016		Lower Price Target	$30.50 ➝ $25.00		View details for S&P Equity Research rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 7/1/2016
MBOT Microbot Medical	$1.82	6/24/2016		Lower Price Target	$0.39 ➝ $0.33		View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 6/24/2016
MBOT Microbot Medical	$1.82	6/17/2016		Lower Price Target	$0.42 ➝ $0.35		View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 6/17/2016
MBI MBIA	$6.31 +2.6%	6/15/2016		Reiterated Rating		Positive	View details for S&P Equity Research rating of MBIA (NYSE:MBI) on 6/15/2016
BHC Bausch Health Cos	$4.96 -0.7%	5/29/2016	Jeffrey Loo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for S&P Equity Research rating of Bausch Health Cos (NYSE:BHC) on 5/29/2016
TSLA Tesla	$404.66 -1.6%	5/20/2016	Efraim Levy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Sell	View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 5/20/2016
FOSL Fossil Group	$4.41 +2.8%	5/13/2016		Downgrade	$22.00	Buy ➝ Strong Sell	View details for S&P Equity Research rating of Fossil Group (NASDAQ:FOSL) on 5/13/2016
MBOT Microbot Medical	$1.82	5/11/2016		Lower Price Target	$3.59 ➝ $2.99		View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 5/11/2016
F Ford Motor	$14.44 -2.3%	5/1/2016	Efraim Levy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$18.00	Strong-Buy	View details for S&P Equity Research rating of Ford Motor (NYSE:F) on 5/1/2016
ABT Abbott Laboratories	$90.64 +2.2%	4/30/2016	Jeffrey Loo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for S&P Equity Research rating of Abbott Laboratories (NYSE:ABT) on 4/30/2016
MBOT Microbot Medical	$1.82	4/27/2016		Lower Price Target	$3.72 ➝ $3.24		View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 4/27/2016
PG Procter & Gamble	$152.38 +1.3%	4/27/2016		Reiterated Rating	$85.00	Hold	View details for S&P Equity Research rating of Procter & Gamble (NYSE:PG) on 4/27/2016
AAPL Apple	$299.24 +1.0%	4/23/2016	Angelo Zino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 4/23/2016
PFE Pfizer	$26.04 +0.2%	4/12/2016	Jeffrey Loo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for S&P Equity Research rating of Pfizer (NYSE:PFE) on 4/12/2016
AAPL Apple	$299.24 +1.0%	3/31/2016	Angelo Zino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 3/31/2016
CAKE Cheesecake Factory	$73.27 -0.7%	3/31/2016		Reiterated Rating	$53.00	Hold	View details for S&P Equity Research rating of Cheesecake Factory (NASDAQ:CAKE) on 3/31/2016
ITV ITV	GBX 81.15 +0.6%	3/28/2016		Boost Price Target	GBX 200 ➝ GBX 240	Buy	View details for S&P Equity Research rating of ITV (LON:ITV) on 3/28/2016
TSLA Tesla	$404.66 -1.6%	3/24/2016		Downgrade	$10.33	Hold ➝ Sell	View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 3/24/2016
BHC Bausch Health Cos	$4.96 -0.7%	3/16/2016		Reiterated Rating	$90.00 ➝ $30.00	Buy	View details for S&P Equity Research rating of Bausch Health Cos (NYSE:BHC) on 3/16/2016
NWBO Northwest Biotherapeutics	$0.19 -0.4%	2/29/2016		Boost Price Target	$1.80 ➝ $2.10		View details for S&P Equity Research rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 2/29/2016
BRK.A Berkshire Hathaway	$742,246.38 +0.0%	2/23/2016		Reiterated Rating	$157.00	Buy	View details for S&P Equity Research rating of Berkshire Hathaway (NYSE:BRK.A) on 2/23/2016
BRK.B Berkshire Hathaway	$494.81 -0.1%	2/22/2016		Reiterated Rating		Buy	View details for S&P Equity Research rating of Berkshire Hathaway (NYSE:BRK.B) on 2/22/2016
AMAT Applied Materials	$568.23 -3.0%	2/19/2016	Angelo Zino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for S&P Equity Research rating of Applied Materials (NASDAQ:AMAT) on 2/19/2016
BEI Beiersdorf Aktiengesellschaft	€70.64 +0.1%	2/18/2016		Set Price Target	€85.00	Neutral	View details for S&P Equity Research rating of Beiersdorf Aktiengesellschaft (ETR:BEI) on 2/18/2016
HEI Heidelberg Materials	€186.40 +2.3%	2/16/2016		Set Price Target	€70.00	Neutral	View details for S&P Equity Research rating of Heidelberg Materials (ETR:HEI) on 2/16/2016
RBGLY Reckitt Benckiser Group	$12.54 +0.3%	2/15/2016		Reiterated Rating		Buy	View details for S&P Equity Research rating of Reckitt Benckiser Group (OTCMKTS:RBGLY) on 2/15/2016
BA Boeing	$227.50 -0.6%	2/12/2016		Reiterated Rating		Buy	View details for S&P Equity Research rating of Boeing (NYSE:BA) on 2/12/2016
CBK Commerzbank	€36.21 -1.7%	2/12/2016		Set Price Target	€8.00	Buy	View details for S&P Equity Research rating of Commerzbank (ETR:CBK) on 2/12/2016
GLEN Glencore	GBX 590.60 +1.3%	2/11/2016		Set Price Target	GBX 65	Sell	View details for S&P Equity Research rating of Glencore (LON:GLEN) on 2/11/2016
DIS Walt Disney	$101.39 -0.3%	2/10/2016		Reiterated Rating		Buy	View details for S&P Equity Research rating of Walt Disney (NYSE:DIS) on 2/10/2016
MRK Merck & Co., Inc.	$115.10 +0.2%	2/5/2016		Reiterated Rating	$56.00	Hold	View details for S&P Equity Research rating of Merck & Co., Inc. (NYSE:MRK) on 2/5/2016
The roadshow starts Monday. This stock isn't ready. (Ad) The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain. Get the stock name and ticker before the roadshow begins
MT ArcelorMittal	€68.48 -1.1%	2/5/2016		Set Price Target	€9.60	Sell	View details for S&P Equity Research rating of ArcelorMittal (NYSE:MT) on 2/5/2016
AZN AstraZeneca	£132.84 +0.6%	2/4/2016		Set Price Target	GBX 4,500	Neutral	View details for S&P Equity Research rating of AstraZeneca (LON:AZN) on 2/4/2016
BBVA Banco Bilbao Viscaya Argentaria	€24.39 +2.3%	2/4/2016		Set Price Target	€6.00	Neutral	View details for S&P Equity Research rating of Banco Bilbao Viscaya Argentaria (NYSE:BBVA) on 2/4/2016
DAI Daimler	€63.08	2/4/2016		Set Price Target	€77.00	Buy	View details for S&P Equity Research rating of Daimler (ETR:DAI) on 2/4/2016
GILD Gilead Sciences	$127.23 +2.4%	2/3/2016		Initiated Coverage		Buy	View details for S&P Equity Research rating of Gilead Sciences (NASDAQ:GILD) on 2/3/2016
BT.A BT Group	GBX 197.05 -2.7%	2/1/2016		Set Price Target	GBX 475	Sell	View details for S&P Equity Research rating of BT Group (LON:BT.A) on 2/1/2016
AMZN Amazon.com	$246.00 0.0%	1/28/2016	Tuna Amobi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$34.25	Buy	View details for S&P Equity Research rating of Amazon.com (NASDAQ:AMZN) on 1/28/2016
BAS Basf	€49.23 -0.6%	1/28/2016		Set Price Target	€57.00	Sell	View details for S&P Equity Research rating of Basf (ETR:BAS) on 1/28/2016
F Ford Motor	$14.44 -2.3%	1/28/2016	Efraim Levy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for S&P Equity Research rating of Ford Motor (NYSE:F) on 1/28/2016
SZG Salzgitter	€59.00 +0.3%	1/28/2016		Set Price Target	€19.00	Sell	View details for S&P Equity Research rating of Salzgitter (ETR:SZG) on 1/28/2016

MarketBeat Community Rating for S&P Equity Research

MarketBeat's community ratings are surveys of what our community members think about S&P Equity Research and other research firms in the last 90 days. Vote "Outperform" if you believe S&P Equity Research's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe S&P Equity Research's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 2.7out of 5 (last 90 days)
2.7 of 5 stars
OUTPERFORM VOTES: 17 Believe will outperform the market
UNDERPERFORM VOTES: 15 Believe will underperform the market

S&P Equity Research Stock Coverage by Sector

S&P Equity Research concentrates its research most heavily in Computer and Technology (100.0%). The chart below shows how S&P Equity Research's 1 rated company is distributed across all 1 sector it covers.

Computer and Technology
1 company
100.0%

Best & Worst Calls

Best Call
000.0%
NYSE:UAA
Boost Price Target • Apr 12, 2013
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
NASDAQ:SUNE
Reiterated Rating • Sep 9, 2015
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

S&P Equity Research - Frequently Asked Questions

S&P Equity Research's analysts currently have buy-equivalent ratings on 1 companies.

S&P Equity Research has the deepest coverage in Computer and Technology (100.0% of rated companies).

S&P Equity Research issued 1 ratings over the last 12 months across 1 companies â€” an average of roughly 0 rating actions per month. These include reiterated rating. MarketBeat tracks every rating change as it's published so you can see the most current S&P Equity Research analyst actions.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?